 |
PDBsum entry 1u3o
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1u3o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Regulation of rhogef activity by intramolecular and intermolecular sh3 domain interactions.
|
 |
|
Authors
|
 |
M.R.Schiller,
K.Chakrabarti,
G.F.King,
N.I.Schiller,
B.A.Eipper,
M.W.Maciejewski.
|
 |
|
Ref.
|
 |
J Biol Chem, 2006,
281,
18774-18786.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
RhoGEFs are central controllers of small G-proteins in cells and are regulated
by several mechanisms. There are at least 22 human RhoGEFs that contain SH3
domains, raising the possibility that, like several other enzymes, SH3 domains
control the enzymatic activity of guanine nucleotide exchange factor (GEF)
domains through intra- and/or intermolecular interactions. The structure of the
N-terminal SH3 domain of Kalirin was solved using NMR spectroscopy, and it folds
much like other SH3 domains. However, NMR chemical shift mapping experiments
showed that this Kalirin SH3 domain is unique, containing novel cooperative
binding site(s) for intramolecular PXXP ligands. Intramolecular Kalirin SH3
domain/ligand interactions, as well as binding of the Kalirin SH3 domain to the
adaptor protein Crk, inhibit the GEF activity of Kalirin. This study establishes
a novel molecular mechanism whereby intramolecular and intermolecular Kalirin
SH3 domain/ligand interactions modulate GEF activity, a regulatory mechanism
that is likely used by other RhoGEF family members.
|
 |
 |
 |
|
 |
|
 |
Figure 4.
FIGURE 4. Mapping of two potential sites on Kal-SH3 for
binding of intramolecular PXXP motifs. A, molecular surface
representations of Kal-SH3 showing residues affected upon
interaction with various PXXP peptides. The lower surface plots
represent an 180° rotation about the z axis of the upper
surface plots. Residues showing chemical shifts upon interaction
with the PXXP peptide are colored as follows. Background was
defined as the maximal chemical shift observed for residues in
the N and C termini, which are disorderedand should not change
upon ligand binding. Residues colored blue have chemical shift
changes of >0.05 ppm for the PLSP peptide and >0.14 ppm for the
PKTP peptide and represent site 1. Residues colored green have
chemical shift changes of >0.14 ppm for the PKTP peptide and
>0.06 ppm for the PLPP peptide and represent site 2. Changes in
chemical shifts not colored in this figure are Val^21 and Ser^63
for the PLSP peptide and Glu^67 for the PKTP peptide. The
canonical PXXP-binding site mapped in other SH3 structures is
shown on the far right (colored magenta) B, alignment of Kalirin
and Trio N-terminal SH3 domains from different species (upper)
with SH3 domains of defined structure with canonical
ligand-binding sites (middle) and non-canonical binding sites
(lower). The frog Kalirin sequence is derived from an expressed
sequence tag that is missing the N-terminal SH3 domain sequence
(dashes). The secondary structure of Kal-SH3 is indicated above
the sequences and is color-coded as described in the legend to
Fig. 2. Kalirin residues that show chemical shift changes of
>0.15 ppm upon binding of the PKTP peptide (330 µM) to the
SH3 domain (590 µM) are colored blue for site 1 and green
for site 2. Numbering is as for the structural determination of
the SH3 domain. Residues colored magenta are ligand-binding
residues observed in the structures of Fyn (Protein Data Bank
code 1AON), c-Src (code 1NLP), Abl (code 1ABO), -spectrin ( -sp;
code 1HD3), Grb2 (N terminus; code 1AZE), c-Crk (N terminus;
code 1CKA), Sem5 (C terminus; code 2SEM), GADS (code 1H3H),
p67^phox (code 1K4U), Pex13p (code 1NM7), Grb2 (C terminus; code
1GFC), and Vav1 (code 1GCQ).
|
 |
Figure 7.
FIGURE 7. Model of how intramolecular SH3 domain/ligand
interactions and intermolecular Kalirin/Crk binding affect GEF
activity. Although our data strongly support two PXXP-binding
sites in Kal-SH3, as depicted in this model (with site 1 colored
blue and site 2 colored green), we cannot rule out a single
PXXP-binding site. The PKTP ligand is indicated by light blue
ovals, and the PLPP ligand by green ovals. Crk is colored red.
The PLSP ligand is located in spectrin repeat 3 (colored cyan).
The Sec14p domain and two N-terminal spectrin repeats in Kal8
are not shown.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2006,
281,
18774-18786)
copyright 2006.
|
 |
|
|
|
|
 |